Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developmental disorders
Article first published online: 27 OCT 2010
Copyright © 2010 Wiley-Liss, Inc.
Developmental Disabilities Research Reviews
Special Issue: Psychopharmacology
Volume 16, Issue 3, pages 273–282, 2010
How to Cite
Rowles, B. M. and Findling, R. L. (2010), Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developmental disorders. Dev Disabil Res Revs, 16: 273–282. doi: 10.1002/ddrr.120
- Issue published online: 27 OCT 2010
- Article first published online: 27 OCT 2010
- Manuscript Accepted: 28 AUG 2010
- Manuscript Received: 15 AUG 2010
- developmental disorder;
- subaverage intelligence;
- attention-deficit/hyperactivity disorder;
Developmental disorders such as subaverage intelligence, pervasive developmental disorders, and genetic syndromes are frequently associated with comorbid attention-deficit/hyperactivity disorder (ADHD) or ADHD-like symptoms. While there are not pharmacological cures for these developmental disorders, coinciding ADHD and ADHD-like symptoms that contribute to difficulties in psychosocial functioning are frequently able to be addressed by pharmacotherapy. This article reviews what is known about the efficacy and tolerability of pharmacological interventions for the treatment of children and adolescents suffering from developmental disorders and comorbid ADHD/ADHD-like symptoms. © 2010 Wiley-Liss, Inc. Dev Disabil Res Rev 2010;16:273–282.